Amanda Gough
Family · Sterling Heights, MINPI 1316419609
Payments from drug & device makers
Across 199 payments — averaging $18.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$636
- Amgen$441
- GSK$352
- Pfizer$269
- Lilly USA, LLC$203
- Exact Sciences$181
- plus $2K from 24 others
What the payments were for
- Food & beverage$3,763100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $636 |
| Amgen | 27 | $441 |
| GSK | 16 | $352 |
| Pfizer | 14 | $269 |
| Lilly USA, LLC | 12 | $203 |
| Exact Sciences | 9 | $181 |
| Esperion Therapeutics, Inc. | 10 | $158 |
| AstraZeneca | 10 | $146 |
| Novo Nordisk | 9 | $146 |
| Boehringer Ingelheim | 6 | $139 |
| Amarin Pharma, Inc. | 8 | $130 |
| Johnson & Johnson | 8 | $123 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $122 |
| Merck | 6 | $117 |
| Astellas Pharma US Inc | 5 | $97 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $96 |
| Aimmune Therapeutics, Inc. | 3 | $57 |
| Bayer | 3 | $56 |
| Halozyme Inc | 2 | $45 |
| E.r. Squibb & Sons, L.L.C. | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Sanofi-aventis U.S. LLC | 1 | $28 |
| Antares Pharma, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Urovant Sciences Inc | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Pulmonx Corporation | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$120
- UBRELVY$107
- VRAYLAR$106
How this compares
$3,763 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 13 | $70,137 |
| JardianceEmpagliflozin | 47 | $43,179 |
| OzempicSemaglutide | 27 | $37,332 |
| EliquisApixaban | 42 | $29,222 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $27,547 |
| XareltoRivaroxaban | 15 | $13,320 |
| MyrbetriqMirabegron | 20 | $12,256 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 67 | $1,379 |
| Atorvastatin Calcium | 146 | $1,368 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 40 | $1,267 |
| Losartan Potassium | 102 | $919 |
| Metoprolol Succinate | 53 | $789 |
| Omeprazole | 76 | $699 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $575 |
| Carvedilol | 75 | $573 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $441 | $70,13713 claims |
| Boehringer IngelheimJardiance | $139 | $43,17947 claims |
| Novo NordiskOzempic | $146 | $37,33227 claims |
| PfizerEliquis | $269 | $29,22242 claims |
| GSKTrelegy Ellipta | $352 | $27,54734 claims |
| Johnson & JohnsonXarelto | $123 | $13,32015 claims |
| Astellas Pharma US IncMyrbetriq | $97 | $12,25620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,657 family providers in Michigan.
Other family in Sterling Heights
- Simona DenkovskiSterling Heights$11K
- Brittany SharpSterling Heights$10K
- Darlene BrownSterling Heights$9K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.